Fresenius Medical Care Stock Analysis
FMS Stock | USD 24.31 0.05 0.21% |
Fresenius Medical Care is overvalued with Real Value of 20.1 and Target Price of 23.45. The main objective of Fresenius Medical stock analysis is to determine its intrinsic value, which is an estimate of what Fresenius Medical Care is worth, separate from its market price. There are two main types of Fresenius Medical's stock analysis: fundamental analysis and technical analysis.
The Fresenius Medical stock is traded in the USA on New York Stock Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Fresenius Medical is usually not traded on Thanksgiving Day, Christmas Day, New Year 's Day, National Mourning Day, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday, Memorial Day, Juneteenth Holiday, Independence Day, Labour Day. Fresenius Stock trading window is adjusted to America/New York timezone.
Fresenius |
Fresenius Stock Analysis Notes
The company has price-to-book (P/B) ratio of 0.9. Some equities with similar Price to Book (P/B) outperform the market in the long run. Fresenius Medical Care has Price/Earnings To Growth (PEG) ratio of 0.49. The entity last dividend was issued on the 17th of May 2024. The firm had 2:1 split on the 4th of December 2012. KGaA provides dialysis care and related dialysis care services in Germany, North America, and internationally. KGaA was incorporated in 1996 and is headquartered in Bad Homburg, Germany. Fresenius Medical is traded on New York Stock Exchange in the United States. To learn more about Fresenius Medical Care call FACHE MBA at 49 6172 609 0 or check out https://www.freseniusmedicalcare.com.Fresenius Medical Quarterly Total Revenue |
|
Fresenius Medical Care Investment Alerts
Latest headline from zacks.com: 4 Value Picks That Could Weather Tariff Volatility and Slowing Growth |
Fresenius Medical Care Upcoming and Recent Events
20th of February 2024 Upcoming Quarterly Report | View | |
14th of May 2024 Next Financial Report | View | |
31st of December 2023 Next Fiscal Quarter End | View | |
20th of February 2024 Next Fiscal Year End | View | |
30th of September 2023 Last Quarter Report | View | |
31st of December 2022 Last Financial Announcement | View |
Fresenius Largest EPS Surprises
Earnings surprises can significantly impact Fresenius Medical's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
---|---|---|---|---|---|---|---|
1999-11-23 | 1999-09-30 | 0.09 | 0.1 | 0.01 | 11 | ||
1999-03-29 | 1998-12-31 | 0.08 | 0.07 | -0.01 | 12 | ||
1997-11-25 | 1997-09-30 | 0.05 | 0.04 | -0.01 | 20 |
Fresenius Medical Environmental, Social, and Governance (ESG) Scores
Fresenius Medical's ESG score is a quantitative measure that evaluates Fresenius Medical's performance and commitment regarding environmental, social, and governance (ESG) factors. These scores are becoming increasingly crucial in investment decision-making processes, providing insights into non-financial aspects of Fresenius Medical's operations that may have significant financial implications and affect Fresenius Medical's stock price as well as guide investors towards more socially responsible investments.
Fresenius Medical Thematic Classifications
In addition to having Fresenius Medical stock in your portfolios, you can add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your favorite investment opportunity, you can then obtain an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility. If you are a result-oriented investor, you can benefit from optimizing one of our existing themes to build an efficient portfolio against your specific investing outlook.
![]() | HealthcareUSA Equities from Healthcare industry as classified by Fama & French |
Fresenius Stock Institutional Investors
Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Shares | Arrowstreet Capital Limited Partnership | 2024-12-31 | 205.5 K | Abc Arbitrage Sa | 2024-12-31 | 186.2 K | Old Mission Capital Llc. | 2024-12-31 | 156.6 K | Broyhill Asset Management, Llc | 2024-12-31 | 150.7 K | Fmr Inc | 147.2 K | Marshall Wace Asset Management Ltd | 2024-12-31 | 129.6 K | Quantinno Capital Management Lp | 2024-12-31 | 127.7 K | Visionpoint Advisory Group, Llc | 2024-12-31 | 110.3 K | Geode Capital Management, Llc | 2024-12-31 | 90.8 K | Pzena Investment Management, Llc | 2024-12-31 | 15.3 M | Fiduciary Management, Inc. Of Milwaukee | 2024-12-31 | 6.3 M |
Fresenius Market Capitalization
The company currently falls under 'Large-Cap' category with a total capitalization of 14.33 B.Fresenius Profitablity
The company has Net Profit Margin of 0.03 %, which implies that it may need a different competitive strategy as even a very small decline in it revenue may erase profits and result in a net loss. This is way below average. In the same way, it shows Net Operating Margin of 0.08 %, which entails that for every 100 dollars of revenue, it generated $0.08 of operating income.Last Reported | Projected for Next Year | ||
Return On Tangible Assets | 0.03 | 0.03 | |
Return On Capital Employed | 0.05 | 0.05 | |
Return On Assets | 0.02 | 0.03 | |
Return On Equity | 0.04 | 0.07 |
Management Efficiency
Fresenius Medical Care has Return on Asset of 0.0285 % which means that on every $100 spent on assets, it made $0.0285 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.0484 %, implying that it generated $0.0484 on every 100 dollars invested. Fresenius Medical's management efficiency ratios could be used to measure how well Fresenius Medical manages its routine affairs as well as how well it operates its assets and liabilities. At this time, Fresenius Medical's Return On Assets are comparatively stable compared to the past year. Return On Equity is likely to gain to 0.07 in 2025, whereas Return On Tangible Assets are likely to drop 0.03 in 2025. At this time, Fresenius Medical's Other Current Assets are comparatively stable compared to the past year. Intangible Assets is likely to gain to about 1.7 B in 2025, whereas Non Current Assets Total are likely to drop slightly above 14.3 B in 2025.Last Reported | Projected for Next Year | ||
Book Value Per Share | 53.74 | 56.43 | |
Tangible Book Value Per Share | (2.63) | (2.76) | |
Enterprise Value Over EBITDA | 5.07 | 9.24 | |
Price Book Value Ratio | 0.88 | 0.84 | |
Enterprise Value Multiple | 7.07 | 6.71 | |
Price Fair Value | 0.88 | 0.84 | |
Enterprise Value | 16.2 B | 13.9 B |
Fresenius Medical Care has shown resilience through effective management strategies. Our analysis examines how these strategies influence financial outcomes and investor returns which helps in understanding the stock's long-term potential.
Technical Drivers
As of the 25th of March, Fresenius Medical shows the Downside Deviation of 1.77, mean deviation of 1.17, and Coefficient Of Variation of 3632.82. Fresenius Medical Care technical analysis allows you to utilize historical prices and volume patterns in order to determine a pattern that computes the direction of the firm's future prices. Please confirm Fresenius Medical Care variance, as well as the relationship between the value at risk and skewness to decide if Fresenius Medical Care is priced favorably, providing market reflects its regular price of 24.31 per share. Given that Fresenius Medical has jensen alpha of 0.0583, we urge you to verify Fresenius Medical Care's prevailing market performance to make sure the company can sustain itself at a future point.Fresenius Medical Care Price Movement Analysis
The output start index for this execution was nineteen with a total number of output elements of fourty-two. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Fresenius Medical middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Fresenius Medical Care. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
Fresenius Medical Outstanding Bonds
Fresenius Medical issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Fresenius Medical Care uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Fresenius bonds can be classified according to their maturity, which is the date when Fresenius Medical Care has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
Dana 575 percent Corp BondUS235822AB96 | View | |
FRESLN 425 02 OCT 50 Corp BondUS358070AB61 | View | |
FMEGR 375 15 JUN 29 Corp BondUS35805BAA61 | View | |
FMEGR 2375 16 FEB 31 Corp BondUS35805BAB45 | View | |
FMEGR 1875 01 DEC 26 Corp BondUS35805BAC28 | View | |
FMEGR 3 01 DEC 31 Corp BondUS35805BAE83 | View | |
Morgan Stanley 3971 Corp BondUS61744YAL20 | View | |
AerCap Global Aviation Corp BondUS00773HAA59 | View |
Fresenius Medical Predictive Daily Indicators
Fresenius Medical intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Fresenius Medical stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Fresenius Medical Corporate Filings
10th of March 2025 Other Reports | ViewVerify | |
6th of March 2025 Other Reports | ViewVerify | |
6K | 25th of February 2025 A report filed by foreign private issuers with SEC. A foreign private issuer is a non-U.S. company with securities traded on U.S. exchanges. | ViewVerify |
6K | 24th of February 2025 A report filed by foreign private issuers with SEC. A foreign private issuer is a non-U.S. company with securities traded on U.S. exchanges. | ViewVerify |
14th of February 2025 Other Reports | ViewVerify | |
6K | 20th of December 2024 A report filed by foreign private issuers with SEC. A foreign private issuer is a non-U.S. company with securities traded on U.S. exchanges. | ViewVerify |
6K | 18th of December 2024 A report filed by foreign private issuers with SEC. A foreign private issuer is a non-U.S. company with securities traded on U.S. exchanges. | ViewVerify |
6K | 12th of December 2024 A report filed by foreign private issuers with SEC. A foreign private issuer is a non-U.S. company with securities traded on U.S. exchanges. | ViewVerify |
Fresenius Medical Forecast Models
Fresenius Medical's time-series forecasting models are one of many Fresenius Medical's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Fresenius Medical's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About Fresenius Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how Fresenius Medical prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Fresenius shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Fresenius Medical. By using and applying Fresenius Stock analysis, traders can create a robust methodology for identifying Fresenius entry and exit points for their positions.
Last Reported | Projected for Next Year | ||
Pretax Profit Margin | 0.05 | 0.08 | |
Operating Profit Margin | 0.07 | 0.13 | |
Net Profit Margin | 0.03 | 0.04 | |
Gross Profit Margin | 0.25 | 0.36 |
Current Fresenius Analysis - Recommendations
We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Fresenius analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Fresenius analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target Price | Advice | # of Analysts | |
23.45 | Buy | 6 | Odds |
Most Fresenius analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Fresenius stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Fresenius Medical Care, talking to its executives and customers, or listening to Fresenius conference calls.
Fresenius Stock Analysis Indicators
Fresenius Medical Care stock analysis indicators help investors evaluate how Fresenius Medical stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Fresenius Medical shares will generate the highest return on investment. By understating and applying Fresenius Medical stock analysis, traders can identify Fresenius Medical position entry and exit signals to maximize returns.
Begin Period Cash Flow | 1.4 B | |
Long Term Debt | 6.3 B | |
Common Stock Shares Outstanding | 293.4 M | |
Total Stockholder Equity | 14.6 B | |
Tax Provision | 316.1 M | |
Quarterly Earnings Growth Y O Y | -0.656 | |
Property Plant And Equipment Net | 7.3 B | |
Cash And Short Term Investments | 1.4 B | |
Cash | 1.2 B | |
Accounts Payable | 984.3 M | |
Net Debt | 9.8 B | |
50 Day M A | 23.864 | |
Total Current Liabilities | 5.7 B | |
Other Operating Expenses | 17.9 B | |
Non Current Assets Total | 25.6 B | |
Forward Price Earnings | 12.21 | |
Non Currrent Assets Other | 198.3 M |
Additional Tools for Fresenius Stock Analysis
When running Fresenius Medical's price analysis, check to measure Fresenius Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Fresenius Medical is operating at the current time. Most of Fresenius Medical's value examination focuses on studying past and present price action to predict the probability of Fresenius Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Fresenius Medical's price. Additionally, you may evaluate how the addition of Fresenius Medical to your portfolios can decrease your overall portfolio volatility.